A reliable payout, a growing cancer treatment lineup, and improving guidance make this drugmaker worth a second look right ...

A new round of federal customs requirements could make it more difficult for Americans who rely on prescription medications ...

Four companies kept raising their dividends even as the pandemic hammered their sectors in 2020, and they are still raising ...

The changes are part of broader efforts to collect customs duties, enforce import laws and prevent prohibited goods, ...

A brief research report found that Medicare beneficiaries taking several commonly prescribed medications could see ...

Bristol-Myers Squibb reported two Phase 3 trial successes (RYZ101 and admilparant) but saw most gains erased as markets ...

Wells Fargo lowered its Bristol Myers Squibb price target from USD 65.00 to USD 60.00 while maintaining an Equal Weight ...

Every big pharma company eventually watches its best-selling drug go generic, yet some keep raising their dividends anyway.

Pfizer shares reached multi-month highs despite broader market inflation declines.A new five-hundred-million-dollar ...